We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Results 1 to 5 of 25
Most popular |Most recent

Premier League: Advocate General opinion worries content owners

United Kingdom - February 28 2011 On 3 February 2011 the Advocate General gave her opinion in the Football Association Premier League v QC Leisure case ("FAPL case")....

Penelope Thornton, John Pheasant.

Reckitt Benckiser admits infringing UK and European competition law by withdrawing and de-listing Gaviscon original liquid from the NHS prescription channel

United Kingdom - December 2 2010 An investigation by the U.K. Office of Fair Trading (OFT) has highlighted whether certain practices associated with product development and regulatory andor patent protection for successor drugs so-called "lifecycle management" can be challenged under UK and EU competition law....

OFT further guidance to help businesses and directors comply with competition law

United Kingdom - November 9 2010 On 19 October 2010, the Office of Fair Trading ("OFT") published for consultation its proposed guidance for company directors in the UK on their duties under competition law....

Lesley Ainsworth.

European court upholds Commission case against AstraZeneca relating to Losec, but reduces fine

European Union - July 16 2010 On 1 July 2010, the General Court of the European Union (the "General Court") handed down its eagerly awaited judgment in relation to AstraZeneca's appeal against a 2005 decision of the European Commission (the "Commission") finding that AstraZeneca had abused its dominant position by blocking or delaying generic versions of its drug Losec....

Lesley Ainsworth.

European Commission issues first report on patent settlements

European Union - July 16 2010 On 5 July 2010, the European Commission (the "Commission") published its first report on its monitoring of patent settlements in the pharmaceutical sector (the "Report")....